0 24 OK J-STAGE3GLP-1 GLP-1 J-STAGE1GLP-1 3 GLP-1 GLP-1 GLP-1 GLP-1(-1) GLP-1 GLP-1 PMDA2.5mg5mg7.5mg10mg12.5mg15mg PMDA2mg PMDA3mg7mg14mg GLP-1 GLP-1 GLP-1 GLP-1 GLP-1GIP/GLP-1 () GLP-1 GLP-1 GLP-1 GLP-1 e- GLP-1 GLP-1 GLP-1 GIP/GLP-1()GLP-1()SGLT2() LINE 0 24 OK DMM DMM 200 24365 GLP-1 DMM OK PC ()() 1,000OFF GLP-1GIP/GLP-1 1()()() 22,000(2.5mg 4) 5,200/(3mg 11) GLP-1GIP/GLP-1SGLT2 GLP-1GIP/GLP-1 PC GLP-1GLP-1 0 24 OK
In postmenopausal subgroup and 12-month landmark analyses, protective associations versus SGLT2 inhibitors were not sustained
Its not a shortcut
The amount of attention a substance receives does not determine its medical value
Treg cells primarily prevented secondary brain injury by coordinating lymphocyte and microglia infiltration in ischemic stroke through IL-10 signaling (78, 79)
Sample size calculations were based on phase 2 trial data, which predicted a treatment difference of 1.0 in the Female Sexual Function Index-desire domain (FSFI-D) score and about 20.43 points in the Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO) item 13, with a total of 450 evaluable patients providing sufficient statistical power to detect significant differences